Biologics Industrial and Market studies - Worldwide Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 –
"Biologics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Global Biologics Market: Scope and Methodology
This report provides forecast and analysis of the global biologics market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook for biologics revenue annually. It includes drivers and restraints of the global biologics market and their impact on each region during the forecast period. The report also comprises the study of applications and opportunities for biologics manufacturers. It also includes a detailed analysis by product type and supply chain analysis with a list of suppliers and industry stakeholders at each node in the supply chain.
Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=879404
Global Biologics Market: Segmentation
The report includes the revenue generated from sales of biologics in all regions and important countries in these regions. By product, the global biologics market has been segmented into monoclonal antibodies, vaccines, recombinant hormones/vaccines, cell therapy, gene therapy and other products. By application type, the market is segmented into oncology, infectious diseases, immunology, auto-immune diseases, and other diseases. Furthermore, the global market is sub-segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Biologics Market: Competitive Landscape
The report provides detailed competitive and company profiles of key participants operating in the global market. Key players in the global biologics market include AbbVie Inc., Amgen Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi.
The market has been segmented as below:
Global Biologics Market – By Product
- Monoclonal Antibodies
- Vaccines
- Recombinant Hormones/Proteins
- Cell Therapy
- Gene Therapy
- Others
Global Biologics Market – By Applications
- Oncology
- Infectious Diseases
- Immunology
- Autoimmune Diseases
- Others
Global Biologics Market – By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- Europe
- Germany
- UK
- Italy
- Spain
- France
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- Japan
- Australia
- New Zealand
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- Saudi Arabia
- UAE
- RSA
- Rest of MEA